Home Tags Medicine

medicine Related Content

drug testing

Stop drug testing and start impairment testing

A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
Turkey and COVID-19, Erdoğan

Turkey and COVID-19: Success, turmoil, insecurity and opportunity

Dr Ahmet Erdi Öztürk, expert on Turkish politics, discusses the ongoing realities of Turkey and COVID-19.
treat COVID-19, drug

Existing drugs should be used to treat COVID-19 instead of vaccine

Researchers say we should repurpose existing drugs, which would be faster than waiting for a "magic bullet" vaccine to treat COVID-19.
rapid testing, antibiotics

It should never have taken COVID-19 for us to value rapid testing

Daniel Berman, Head of Global Health, Nesta Challenges, says that it should not have taken COVID-19 to emphasise the necessity of rapid testing.
PPE acquisition, police

PMQ’s summary: The NHS, PPE acquisition and knife crime

On 29 April, First Secretary Dominic Raab discussed government plans in relation to crucial issues such as PPE acquisition and knife crime.
clinical trials and clinical care, wearables

Bridging the gap between clinical trials and clinical care

Here, Tatiana Affini Dicenzo and Freimut Schliess discuss bridging the gap between clinical trials and clinical care, specifically exploring if wearables are fit for this purpose.
Hong kong COVID-19, COVID-19 strategy

The science behind the Hong Kong COVID-19 strategy

Currently, the country has only experienced four deaths: What is the Hong Kong COVID-19 strategy and why is it working so well?
access to quality data, medical data

Will tech democratise access to quality healthcare?

Neil Ballinger, head of EMEA sales at EU Automation, explains how greater access to quality healthcare can come from medical data and AI.
maturing cannabis market, cannabis

Growing pains: Creating value in the maturing cannabis market

Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.
EU response to COVID-19, Horizon Europe

Economic and scientific experts discuss EU response to COVID-19

Here we summarise a discussion with experts on the EU response to COVID-19 and the role of Horizon Europe in this pandemic.
early stages of COVID-19, ACE2

Researchers test drug that stops early stages of COVID-19

Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
cannabinoids in medicine, epilepsy

Cannabinoids in medicine part 4: Epilepsy

In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.
cannabis for medicinal and research,

Malta’s stance on cannabis for medicinal and research purposes

Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.

Medical education: Past and present

L. Maximilian Buja, MD, Professor of Pathology and Laboratory Medicine at McGovern Medical School, The University of Texas Health Science Center at Houston, turns the spotlight onto medical education both past and present.
World Glaucoma Week

World Glaucoma Week: The importance of eye examinations

In recognition of World Glaucoma Week, The Association of British Dispensing Opticians (ABDO) highlights how a simple eye test is a key way to detect Glaucoma.
breakthrough in stroke treatment, invasive surgery

Researchers make breakthrough in stroke treatment

An international research team has made a breakthrough in stroke treatment, with a drug that could stop brain swelling without invasive surgery.
lower back pain, vitamin D deficiency

Post-menopause vitamin D deficiency linked to lower back pain

A new study has identified that vitamin D deficiency is one of the key causes of increased disc degeneration and lower back pain.
uk cancer funding, NCRI

UK cancer funding reaches £700 million for first time

The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
reasons behind depression, amygdala

Researchers explore biological reason behind depression

Here, we look at MRI research on brain abnormalities that could be the biological reason behind depression.
MS and Prostate Cancer, cannabinoids

Healing with cannabinoids: MS and Prostate Cancer

Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.

Follow Open Access Government